Login / Signup

Incidental detection in the DANCAVAS trial was limited by design and did not bias the cost effectiveness conclusion.

Rikke SøgaardAxel Cosmus Pyndt DiederichsenJes Lindholt
Published in: European heart journal (2022)
Keyphrases
  • phase iii
  • study protocol
  • loop mediated isothermal amplification
  • clinical trial
  • phase ii
  • real time pcr
  • label free
  • randomized controlled trial
  • sensitive detection